The present invention relates to a digestible carbohydrate composition comprising at least 65% (w/w) glucose-based saccharides on a dry basis, wherein said saccharides have a reducing end and D-glucose monomers linked with alternating α1-6 and α1-3 glycosidic linkages, wherein a maltose unit is present at the reducing end; and 0.1 to 30% (w/w) of fructose equivalents on a dry basis; wherein said glucose-based saccharides have an average degree of polymerization greater than 12.

The present invention relates to a digestible carbohydrate composition comprising at least 65% (w/w) glucose-based saccharides on a dry basis, wherein said saccharides have a reducing end and D-glucose monomers linked with alternating α1-6 and α1-3 glycosidic linkages, wherein a maltose unit is present at the reducing end; and 0.1 to 30% (w/w) of fructose equivalents on a dry basis; wherein said glucose-based saccharides have an average degree of polymerization greater than 12.

The present invention relates to the field of nutraceuticals, and in particular to nutraceuticals comprising sulfated polysaccharides, Astragalus polysaccharides, resveratrol, and combinations thereof. These compositions find use in inducing physiological responses such, decreasing body fat, increasing lean body mass, alleviating the symptoms of colds, preventing the onset of colds, increasing energy, increasing the feeling of well-being in subjects, and improving skin tone and appearance.

The present invention relates to the field of nutraceuticals, and in particular to nutraceuticals comprising sulfated polysaccharides, Astragalus polysaccharides, resveratrol, and combinations thereof. These compositions find use in inducing physiological responses such, decreasing body fat, increasing lean body mass, alleviating the symptoms of colds, preventing the onset of colds, increasing energy, increasing the feeling of well-being in subjects, and improving skin tone and appearance.

A method for determining the flexion or extension of a joint of a human or animal subject, comprising: applying a plurality of strain gauges to the joint in a known configuration; applying a first inertial measurement unit, IMU, to each strain gauge; receiving strain data from each of the strain gauges; receiving motion data from each of the IMUs; and calculating the flexion or extension of the joint in dependence on the received strain data, motion data and the configuration of the strain gauges.

A method for determining the flexion or extension of a joint of a human or animal subject, comprising: applying a plurality of strain gauges to the joint in a known configuration; applying a first inertial measurement unit, IMU, to each strain gauge; receiving strain data from each of the strain gauges; receiving motion data from each of the IMUs; and calculating the flexion or extension of the joint in dependence on the received strain data, motion data and the configuration of the strain gauges.

The present disclosure provides soluble dietary fibers, food and beverage products including them, and methods for making and using them. In one aspect, the disclosure provides soluble dietary fiber having a fiber content of at least 97% as measured by AOAC 2001.03 and a DP1+DP2 content of no more than 3 wt % (e.g., no more than 2 wt %) on a dry solids basis. The soluble dietary fiber can be useful in variety of food and beverage applications including fermented foods and beverages like beer and sake, as well as foods and beverages useful in keto diets.

Described herein are pet food compositions comprising greater than 35 wt. % fat, greater than 10 wt. % fiber, protein, low levels of carbohydrates, and a ketogenic ratio greater than or equal to 1.5. Methods of making and using these pet food compositions are also described herein.

Described herein are pet food compositions comprising greater than 35 wt. % fat, greater than 10 wt. % fiber, protein, low levels of carbohydrates, and a ketogenic ratio greater than or equal to 1.5. Methods of making and using these pet food compositions are also described herein.

The present invention relates to a composition including an anthocyanin-fucoidan complex formed by ionic bond between anthocyanin and fucoidan as an active ingredient, and more particularly, it is confirmed that the anthocyanin-fucoidan complex in which anion of the fucoidan, which is a natural extract having high biocompatibility and biodegradability, is ionically bonded with a cation of the anthocyanin improves the stability and the solubility of the anthocyanin even in acidic conditions in vivo, thereby increasing the immune activity in vivo and therefore it is intended to provide the anthocyanin-fucoidan complex as an immune enhancer, an immune-cancer agent and an anticancer adjuvant composition for alleviating side effects of anti-cancer agents.